Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Alto Neuroscience
Age
18–69
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Have a diagnosis of moderate to severe major depressive disorder (MDD) and/or post-traumatic stress disorder (PTSD)
At baseline, either not taking an antidepressant medication, or currently taking a SSRI, SNRI, mirtazapine, or bupropion for at least 6 weeks with no dose modifications in the past 2 weeks
Willing to comply with all study assessments and procedures
Must not be pregnant or breastfeeding at time of enrollment or throughout study
You may not be if
Evidence of unstable cardiovascular, respiratory, liver, or renal impairment or disease
Active suicidal ideation
Diagnosed bipolar disorder, psychotic disorder, or dementia
Current moderate or severe substance use disorder
Has a history of hypersensitivity or allergic reaction to ALTO-100 or any of its components/excipients
Concurrent or recent participation in another clinical trial for mental illness involving an investigational product or device
